LncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR?18a?5p/SOX6 signaling axis.

ABSTRACT: An increasing number of studies have demonstrated that long non?coding (lnc)RNAs are associated with tumor invasion, metastasis and the prognosis of patients with a variety of different tumors. However, the roles of lncRNA prostate androgen regulated transcript 1 (PART1) in esophageal squamous cell carcinoma (ESCC) remain unknown. In the present study, reverse transcription?quantitative PCR was performed to investigate the levels of PART1, SRY?box transcription factor 6 (SOX6) and miR?18a?5p in ESCC tissues and cells. The functions of PART1 in ESCC were demonstrated using Cell Counting Kit?8 and Matrigel assays. Promoter activity and dual?luciferase reporter assays, RNA immunoprecipitation and western blot analyses were also used to determine the potential mechanisms of PART1 in ESCC cell lines. It was found that PART1 and SOX6 were both downregulated in ESCC tissues and cells, and their low expression levels were associated with TNM stage, lymph node metastasis and poor prognosis in patients with ESCC. Forkhead box protein P2 (FOXP2) exhibited low expression level in ESCC tissues, and its expression was positively correlated with PART1 expression level in ESCC tissues. FOXP2 was found to bind to the promoter region of PART1 to regulate its expression in ESCC cells. Functionally, PART1 overexpression suppressed cell proliferation and invasion, whereas PART1 downregulation promoted cell proliferation and invasion in the ESCC cell lines. Mechanistically, PART1 functions as a competing endogenous (ce)RNA by sponging miR?18a?5p, resulting in the upregulation of the downstream target gene, SOX6, coupled with the inactivation of the ??catenin/c?myc signaling axis, to suppress ESCC cell proliferation and invasion. In conclusion, data from the present study unveil a potential ceRNA regulatory pathway, in which PART1 affects SOX6 expression level by sponging miR?18a?5p, to ultimately suppress ESCC development and progression.

SUBMITTER: Zhao Y 

PROVIDER: S-EPMC7859983 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature